KKKatherine L. Knight

Katherine L. Knight

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katherine L. Knight has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Shi-Kang Zhai

    Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA

    4 shared publications
  • Domenick E. Kennedy

    Department of Medicine, Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, USA

    3 shared publications
  • Francis Alonzo

    Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA

    3 shared publications
  • Olga Kalinina

    Department of Microbiology and Immunology, Loyola University Chicago, Maywood, USA

    3 shared publications
  • Anne I. Sperling

    Department of Medicine, University of Virginia, Charlottesville, VA, USA

    2 shared publications
  • Candace R. Winstead

    Department of Microbiology and Immunology, Loyola University of Chicago, Maywood, IL 60153, USA

    2 shared publications

Latest Publications

  • Open Access

    IgM+IgD− B cells in human gut-associated lymphoid tissue have memory features and give rise to IgM+ and IgA+ antibody-secreting cells

    by Ameera M. Bukhari, Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak, Katherine L. Knight

    Human IgM+ B cells vary in their surface levels of IgD, with the major circulating population of IgM+IgD+ cells and a minor population (< 5%) of IgM+IgD− cells. In contrast, in gut-associated lymphoid tissue (GALT) derived from individuals undergoing tonsillectomy or appendectomy, IgM+IgD− B cells constitute ~ 30% of B cells. IgM+IgD− cells isolated from both tonsil and appendix lack plasma cell and B1 cell markers, and approximately 50% express the memory marker CD27. Functionally, GALT IgM+IgD− cells spontaneously secrete IgM, and class-switch to IgA in response to both T-dependent and T-independent stimulation ex-vivo. Immune repertoire profiling reveals that GALT IgM+IgD− cells exhibit lower levels of VH4-34 rearrangements, higher levels of somatic hypermutation, shorter CDR3 sequences and greater clonal overlap with switch memory cells than IgM+IgD+ cells. Furthermore, clonal lineage analysis reveals that IgM+IgD− clones can include class-switched sequence variants. These findings suggest a maturational scheme starting from CD27−IgM+IgD+ B cells to CD27+IgM+IgD+, and then to CD27−IgM+IgD−, and finally to CD27+IgM+IgD− B cells. In sum, IgM+IgD− B cells in the mucosa have memory features, give rise to class-switched memory B cells and antibody-secreting cells, and likely contribute significantly to the IgA repertoire in human GALT.


  • Bacillus Subtilis–Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in Vitiligo

    by Ahmed A. Touni, Sara Muttar, Zoya Siddiqui, Rohan S. Shivde, Emily Krischke, Digvijay Paul, Mohamed A. Youssef, Anne I. Sperling, Rasha Abdel-Aziz, Hossam Abdel-Wahab, et al.


  • Open Access

    Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease

    by Olga Kalinina, Lisa M. Minter, Anne I. Sperling, Maile K. Hollinger, Phong Le, Barbara A. Osborne, Shubin Zhang, Patrick Stiff, Katherine L. Knight


  • Mechanism of TLR4-Mediated Anti-Inflammatory Response Induced by Exopolysaccharide from the Probiotic Bacillus subtilis

    by Jesus Zamora-Pineda, Olga Kalinina, Anne I Sperling, Katherine L. Knight

    Intestinal inflammatory diseases affect millions of people worldwide, and one class of drugs showing promise toward treatment of several inflammatory diseases is probiotics. Numerous studies have been performed using probiotics to prevent and treat intestinal inflammatory diseases. Most of these studies used intact bacteria, and neither the active molecule nor the molecular mechanisms by which they affect immune responses are known. We have shown that the probiotic Bacillus subtilis is anti-inflammatory and can protect mice from acute colitis induced by the enteric pathogen Citrobacter rodentium. We identified and purified the active molecule, exopolysaccharide (EPS), and showed that it protects mice from C. rodentium–induced colitis by inducing anti-inflammatory M2 macrophages or inhibitory dendritic cells (DCs), both of which inhibit excessive T cell responses. We showed previously that EPS affects macrophages and DCs in a TLR4-dependent manner, and in the current study we asked how EPS induces these anti-inflammatory cells and how they function to inhibit T cells. By investigating the signaling downstream of TLR4 that leads to acquisition of inhibitory properties of macrophages and DCs, we found that EPS induces expression of the inhibitory molecule IDO in bone marrow–derived DCs, and that inhibition of T cell proliferation by IDO-expressing bone marrow–derived DCs utilizes the kynurenine/aryl hydrocarbon receptor circuit. Furthermore, unlike LPS, EPS does not induce inflammatory cytokines upon injection in vivo, directly demonstrating different outcomes induced by two different TLR4 agonists.


  • Open Access

    Death of tonsillar B cells by NETosis

    by Ameera Bukhari, Olga Kalinina, Katherine L. Knight

    Regulating B cell death is essential for generating antibodies and maintaining immune tolerance. B cells can die by apoptosis, and we report that human tonsil B cells, but not peripheral blood B cells also die by NETosis. This cell death is density-dependent, characterized by the loss of cell and nuclear membrane integrity, release of reactive oxygen species, and chromatin decondensation. Tonsil B cells secrete high levels of TNF, and inhibiting TNF prevented chromatin decondensation. By in situ fluorescence microscopy, B cell NETosis, as identified by the hyper citrullination of Histone-3, was localized to the light zone (LZ) of germinal centers in normal tonsil and overlapped with the B cell marker CD19/IgM. We propose a model in which stimulation of B cells in the LZ induces NETosis, driven in part by TNF. We also provide evidence that NETosis of tonsil B cells may be inhibited by an unidentified factor in tonsil. The results describe a previously unidentified form of B cell death and suggest a new mechanism to maintain B cell homeostasis during immune responses.


  • Open Access

    Probiotic Molecules That Inhibit Inflammatory Diseases

    by Jesus Zamora-Pineda, Olga Kalinina, Barbara A. Osborne, Katherine L. Knight

    Consumption of probiotics for health purposes has increased vastly in the past few decades, and yet the scientific evidence to support health benefits from probiotics is only beginning to emerge. As more probiotics are studied, we are beginning to understand the mechanisms of action by which they benefit human health, as well as to identify the bacterial molecules responsible for these benefits. A new era of therapeutics is on the horizon in which purified molecules from probiotics will be used to prevent and treat diseases. In this review, we summarize the active molecules from probiotic bacteria that have been shown to affect innate and adaptive immunity and have health benefits in experimental settings. We focus particularly on the cellular and molecular mechanisms of the probiotic Bacillus subtilis and its active molecule, exopolysaccharide (ESPBs).


  • Amelioration of Graft-versus-Host Disease by Exopolysaccharide from a Commensal Bacterium

    by Olga Kalinina, Sarah Talley, Jesus Zamora-Pineda, Wonbeom Paik, Edward M. Campbell, Katherine L. Knight

    Acute graft-versus-host disease (aGvHD) is a severe, often lethal, complication of hematopoietic stem cell transplantation, and although prophylactic regimens are given as standard pretransplantation therapy, up to 60% of these patients develop aGvHD, and require additional immunosuppressive intervention. We treated mice with a purified probiotic molecule, exopolysaccharide (EPS) from Bacillus subtilis, shortly before and after induction of aGvHD and found that, whereas only 10% of control mice survived to day 80, 70% of EPS-treated mice survived to 80 d. EPS treatment of donor-only mice resulted in ∼60% survival. Using a biosensor mouse model to assess inflammation in live mice during aGvHD, we found that EPS prevented the activation of alloreactive donor T cells. In vitro, EPS did not affect T cells directly but, instead, induced bone marrow–derived dendritic cells (BMDCs) that displayed characteristics of inhibitory dendritic cells (DCs). Development of these BMDCs required TLR4 signaling through both MyD88 and TRIF pathways. Using BMDCs derived from IDO knockout mice, we showed that T cell inhibition by EPS-treated BMDCs was mediated through the suppressive effects of IDO. These studies describe a bacterial molecule that modulates immune responses by inducing inhibitory DCs in a TLR4-dependent manner, and these cells have the capacity to inhibit T cell activation through IDO. We suggest that EPS or EPS-treated DCs can serve as novel agents for preventing aGvHD. Key Points EPS treatment increases survival of mice undergoing GvHD from 10 to 70%. EPS induces inhibitory BMDCs that inhibit alloreactive T cell proliferation in MLR. Inhibitory activity of EPS–BMDCs is mediated by IDO. Visual Abstract


  • Suppression of Staphylococcus aureus Superantigen-Independent Interferon Gamma Response by a Probiotic Polysaccharide

    by Wonbeom Paik, Francis Alonzo, Katherine L. Knight

    Staphylococcus aureusis a Gram-positive opportunistic pathogen that causes a variety of diseases. Bloodstream infection is the most severe, with mortality rates reaching 20 to 50%. Exopolysaccharide (EPS) from the probioticBacillus subtilisreduces bacterial burden and inflammation duringS. aureusbloodstream infection in mice.


  • Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice

    by Emilia R. Dellacecca, Cormac Cosgrove, Zhussipbek Mukhatayev, Suhail Akhtar, Victor H. Engelhard, Alfred W. Rademaker, Katherine L. Knight, I. Caroline Le Poole


  • A Caspase-1 Biosensor to Monitor the Progression of Inflammation In Vivo

    by Sarah Talley, Olga Kalinina, Michael Winek, Wonbeom Paik, Abigail R. Cannon, Francis Alonzo, Mashkoor A Choudhry, Katherine L. Knight, Edward M. Campbell

    Inflammasomes are multiprotein complexes that coordinate cellular inflammatory responses and mediate host defense. Following recognition of pathogens and danger signals, inflammasomes assemble and recruit and activate caspase-1, the cysteine protease that cleaves numerous downstream targets, including pro–IL-1β and pro–IL-18 into their biologically active form. In this study, we sought to develop a biosensor that would allow us to monitor the initiation, progression, and resolution of inflammation in living animals. To this end, we inserted a known caspase-1 target sequence into a circularly permuted luciferase construct that becomes bioluminescent upon protease cleavage. This biosensor was activated in response to various inflammatory stimuli in human monocytic cell lines and murine bone marrow–derived macrophages. Next, we generated C57BL/6 transgenic mice constitutively expressing the caspase-1 biosensor. We were able to monitor the spatiotemporal dynamics of caspase-1 activation and onset of inflammation in individual animals in the context of a systemic bacterial infection, colitis, and acute graft-versus-host disease. These data established a model whereby the development and progression of inflammatory responses can be monitored in the context of these and other mouse models of disease.